Serial 98199739
Live / Registered — Registered (as of 29 Jul 2025)
What this means for you
Registered since 29 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98199739
- Registration number
- 7874907
- Mark type
- Design / logo
- Filed
- 27 Sept 2023
- Published for opposition
- 02 Jul 2024
- Registered
- 29 Jul 2025
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the treatment of anemia
Owner
- Akebia Therapeutics, Inc., Cambridge, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 17 Sept 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 29 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jan 2025 — USE AMENDMENT FILED
- 18 Jun 2025 — SOU EXTENSION 1 GRANTED
- 24 Feb 2025 — SOU EXTENSION 1 FILED
- 16 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 27 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED